India Sector Consolidation Regulatory Filings — July 24, 2026

24-07-2026

Apar Industries Limited reported consolidated revenue from operations of ₹6,591.06 Cr for Q1 FY27 (ended June 30, 2026), up 29.1% YoY from ₹5,104.16 Cr in Q1 FY26. Consolidated profit after tax surged 77.8% YoY to ₹467.45 Cr from ₹262.91 Cr. However, the Transformer and Speciality Oils segment saw a sharp sequential decline in profit (from ₹81.87 Cr in Q4 FY26 to ₹331.34 Cr in Q1 FY27, though this is a large sequential increase, not a decline; the segment profit was ₹97.78 Cr in Q1 FY26, so YoY growth is strong). The Power/Telecom Cables segment profit fell 37.1% YoY to ₹83.07 Cr from ₹132.09 Cr, and the Conductors segment profit grew only 16.2% YoY to ₹274.40 Cr, lagging revenue growth. The company also approved incorporation of a wholly owned subsidiary in the UK and further investment of up to BRL 3,000,000 in its Brazil subsidiary.

• · Consolidated total comprehensive income for Q1 FY27 was ₹328.89 Cr, up 21.8% from ₹270.04 Cr in Q1 FY26.
• · Standalone revenue from operations for Q1 FY27 was ₹6,477.35 Cr, up 32.7% from ₹4,881.09 Cr in Q1 FY26.
• · Standalone profit after tax for Q1 FY27 was ₹453.05 Cr, up 75.7% from ₹257.86 Cr in Q1 FY26.
• · Consolidated basic EPS for Q1 FY27 was ₹116.37, up from ₹65.45 in Q1 FY26.
• · The company infused USD 50,00,000 in Apar USA LLC and ₹10.75 Cr in Cleanmax Rudra associate during the quarter.
• · Exceptional items in the previous year included a provision of ₹32.53 Cr (consolidated) for past service cost on gratuity and compensated absences.
• · The Board approved incorporation of a wholly owned subsidiary in the United Kingdom.
• · The Board approved further investment of up to BRL 3,000,000 in Apar Industries Latam Ltda, Brazil.

24-07-2026

Dr. Lal PathLabs Ltd. reported consolidated revenue of ₹7,977 million for Q1 FY27 (June 2026), up 19.1% YoY from ₹6,698 million, and net profit of ₹1,705 million, up 27.2% YoY from ₹1,340 million. However, the preceding quarter (Q4 FY26) showed a sequential revenue decline of 11.9% from ₹7,027 million, though profit rose 29.0% sequentially. The Board approved an interim dividend of ₹5 per share and noted two subsidiary-level acquisitions: an 80% stake in Sunshine Healthcare Limited (Ghana) and a stake in Neuome Technologies Private Limited (India).

• · Total expenses for Q1 FY27 were ₹6,009 million, up 16.3% YoY from ₹5,168 million.
• · Other income for Q1 FY27 was ₹319 million, up 13.5% YoY from ₹281 million.
• · Finance costs for Q1 FY27 were ₹63 million, up 34.0% YoY from ₹47 million.
• · Depreciation and amortisation expense for Q1 FY27 was ₹444 million, up 28.3% YoY from ₹346 million.
• · Fees to collection centers/channel partners for Q1 FY27 were ₹1,158 million, up 20.9% YoY from ₹958 million.
• · The record date for the interim dividend is July 30, 2026.
• · The Board of Dr. Lal PathLabs FZCO approved acquisition of 80% stake in Sunshine Healthcare Limited (Ghana) for consideration not exceeding GHS 45.60 million.
• · The Board of Dr. Lal Ventures Private Limited approved acquisition of stake in Neuome Technologies Private Limited (India).
• · During Q1 FY27, the company acquired 100% of Shahbazkers Diagnostic Centre Private Limited for ₹200 million cash, resulting in goodwill of ₹143 million.
• · A further investment of ₹77.5 million was made in Dr. Lal Ventures Private Limited during the quarter.
• · Four unaudited subsidiaries contributed total revenue of ₹76.39 million and total profit after tax of ₹8.66 million for Q1 FY27.
• · Paid-up equity share capital stood at ₹1,676 million as of June 30, 2026 (face value ₹10 per share).
• · Other equity as of March 31, 2026 (audited) was ₹23,406 million.

24-07-2026

Welspun Corp Limited's Board approved unaudited consolidated financial results for Q1 FY27 (quarter ended June 30, 2026), showing revenue of ₹4,081.12 Cr (up 14.9% YoY) and net profit of ₹1,047.88 Cr (up 200.1% YoY), boosted by a ₹547.93 Cr gain on sale of an associate stake. The Board also approved the acquisition of an additional 51% equity stake in Welspun Captive Power Generation Limited (WCPGL) from Welspun Living Limited for ₹67.66 Cr, increasing total ownership from 23% to 74%, making WCPGL a subsidiary. However, revenue declined 5.4% sequentially from ₹4,312.56 Cr in Q4 FY26, and the company reported a net loss of ₹39.78 Cr from 8 unaudited subsidiaries.

• · The Board approved an investment of ₹26,000 (26% of paid-up equity) in a new company to be incorporated in India.
• · The acquisition of WCPGL shares is subject to execution of transaction documents and statutory/regulatory approvals.
• · The unaudited consolidated results include a ₹547.93 Cr profit on sale of shares of an associate (not separately identified).
• · 8 subsidiaries (unaudited) reported total revenues of ₹46.68 Cr and a net loss of ₹39.78 Cr for the quarter.
• · 3 associates (unaudited) contributed a net profit of ₹3.09 Cr to the Group.
• · The limited review report includes a qualification regarding an overseas associate whose financials were converted from local GAAP to Ind AS.

24-07-2026

Jamna Auto Industries Ltd. has approved the acquisition of 100% of Owen Springs Limited, a UK-based manufacturer of leaf and parabolic springs, for a cash consideration of £2,000,000 (subject to net current asset adjustments). The acquisition aligns with Jamna Auto's 'Lakshya – RISE 5000' strategy to expand into new markets and strengthen its international presence. However, Owen Springs has shown a declining revenue trend over the last three years, with revenue falling from £3,854 thousand in 2023 to £2,760 thousand in 2025, and reported a modest PAT of £132 thousand and net worth of £1,041 thousand as of December 2025.

• · Owen Springs was incorporated on July 28, 2004, in England and Wales.
• · The acquisition is expected to be completed by August 31, 2026.
• · The consideration is 100% cash, subject to adjustments to net current assets per the Share Purchase Agreement.
• · The acquisition is not a related party transaction.
• · No governmental or regulatory approvals are required for the acquisition.

24-07-2026

Dachepalli Publishers Ltd has executed a non-binding MoU to acquire 100% of Hara Communications Private Limited, a move intended to expand its educational technology business. The acquisition is subject to due diligence, definitive agreements, and regulatory approvals, and would make Hara Communications a wholly owned subsidiary. No financial terms, valuation, or timeline were disclosed, and the deal remains contingent on multiple conditions precedent.

• · The MoU is non-binding and subject to due diligence, definitive agreements, statutory/regulatory approvals, and customary conditions precedent.
• · The proposed acquisition is in line with the company's long-term growth strategy to strengthen its presence in the education sector.
• · No financial details, valuation, or expected completion timeline were provided in the filing.

24-07-2026

Standard Glass Lining Technology Limited (now Standard Engineering Technology Limited) completed Phase I of a strategic investment in GL HAKKO Co., Ltd., Japan, acquiring 19.19% stake. Phase II contemplates an additional up to 31.88% within three years, potentially increasing total stake to 51.07%, subject to regulatory approvals.

• · Phase I investment completed via remittance through prescribed banking channels.
• · Share Subscription Agreement and Shareholders' Agreement executed.
• · Phase II subject to FEFTA approval and other conditions.
• · Company name changed to Standard Engineering Technology Limited.

24-07-2026

Sun Pharmaceutical Industries Limited announced that stockholders of Organon & Co. have approved the proposed merger transaction, under which Organon is expected to become a wholly owned subsidiary of Sun Pharmaceutical Holdings USA, Inc., an indirect wholly owned subsidiary of Sun Pharma. This shareholder approval is a key milestone, though the acquisition remains subject to remaining customary closing conditions and applicable regulatory approvals. No financial terms or performance metrics were disclosed in this filing.

• · The acquisition was originally announced on April 27, 2026.
• · The transaction is expected to close upon satisfaction of remaining customary closing conditions and regulatory approvals.
• · Sun Pharma's Global Innovative Medicines portfolio accounts for about 22% of company sales.

24-07-2026

Aspect Global Ventures Private Limited acquired 69,59,800 equity shares (70.61% stake) of Duke Offshore Limited on July 21, 2026, pursuant to a Share Purchase Agreement dated June 11, 2026. The acquisition was made from sellers George Albert Donald Duke, Avik George Duke, and Komal Duke. Post-acquisition, Aspect Global Ventures holds 70.61% of the total voting capital and will be classified as a Promoter with effect from July 21, 2026.

• · The acquisition was executed under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
• · Aspect Global Ventures had no prior holding in Duke Offshore Limited before this acquisition.
• · The total diluted share capital of the target company remains unchanged at 98,57,200 equity shares of ₹10 each.
• · The acquirer will be classified as a Promoter with effect from July 21, 2026.

24-07-2026

AXISCADES Technologies Limited has completed the acquisition of a 32,847 sq. m. land parcel in Telangana's IP Hardware Park Phase II from TSIIC for a total consideration of ₹39,41,64,000. The land will be used to set up a Defence Hardware Manufacturing & Article integration unit (without fuel & explosives). The transaction is not with a related party and does not fall under related party transactions.

• · The acquisition was completed in accordance with terms agreed with TSIIC.
• · The land is situated at IP Hardware Park Phase II, Mamidipally village, Balapur Mandal, Rangareddy District, Telangana.
• · No shareholding exists between the company and the seller.
• · The seller is not related to promoter/promoter group/group companies.
• · The transaction is not a related party transaction.

24-07-2026

ACC Limited reported standalone revenue from operations of ₹5,748 Crore for Q2 FY26 (quarter ended June 30, 2026), down 9.8% YoY from ₹6,256 Crore in Q2 FY25, and profit after tax fell 61.6% YoY to ₹148 Crore from ₹385 Crore. The Board also approved the acquisition of a 26% stake in Amplus Andhra Power Private Limited for approximately ₹53.1 Mn (cash consideration) to offtake electricity as a captive user. While total expenses decreased 3.4% YoY, the company booked a ₹24 Crore exceptional charge for a voluntary severance scheme, and the prior-year quarter had no such charge.

• · Standalone revenue from operations for the preceding quarter (ended March 31, 2026) was ₹7,054 Crore, indicating a sequential decline of 18.5% to ₹5,748 Crore in the current quarter.
• · Other income fell 14.5% YoY to ₹59 Crore from ₹69 Crore.
• · Finance costs decreased 10% YoY to ₹27 Crore from ₹30 Crore.
• · The company recognized a receivable/credit of ₹93 Crore as of June 30, 2026 related to Infrastructure Development Cess and Environment Cess in Chhattisgarh, following a favorable High Court judgment.
• · During the previous year ended March 31, 2026, the company reversed ₹594 Crore of tax provisions based on favorable High Court decisions and received tax refunds of ₹205 Crore.
• · The amalgamation scheme with Ambuja Cements Limited received no-objection certificates from BSE and NSE on June 4, 2026, and a joint company application has been filed with NCLT.
• · Amplus Andhra Power Private Limited's total revenue declined from ₹99.40 Mn in FY23 to ₹85.40 Mn in FY25.